Core Insights - Lectra has released its Management Discussion and Analysis of Financial Condition and Results of Operations for Q3 and the first nine months of 2025, which is available on its website [1][2] Company Overview - Founded in 1973, Lectra specializes in industrial intelligence technology solutions, integrating SaaS software, cutting equipment, data, and associated services for the fashion, automotive, and furniture industries [3] - The company emphasizes innovation and transformation, leveraging Industry 4.0 technologies such as AI, big data, cloud, and the Internet of Things [3] - Lectra operates in over 100 countries and has three production sites for cutting equipment located in France, China, and the United States [4] - The company employs around 3,000 individuals who are guided by core values of open-mindedness, trust, and passion for innovation, with a strong focus on social responsibility [4] Financial Performance - In 2024, Lectra reported revenues of €527 million, with €77 million derived from its SaaS offerings [5] - The company is publicly listed on Euronext and is part of several indices, including CAC All Shares, CAC Technology, EN Tech Leaders, and ENT PEA-PME 150 [5]

Verkkokauppa.com Oyj, Stock Exchange Release, 29 October 2025 at 07:00 p.m. EET Verkkokauppa.com Oyj: Acquisition of own shares on 29 October 2025 Date29 October 2025 Exchange transactionBuy Share trading codeVERK Amount, shares13,546 Average price/share (EUR)4.0050 Total cost (EUR)54,251.73 After the acquisitions Verkkokauppa.com Oyj holds a total of 75,991 treasury shares. On behalf of Verkkokauppa.com Oyj Danske Bank A/S, Finland BranchAntti Väliaho Jonathan Nyberg For more information, please contact: ...

Amsterdam, 29 October 2025 EXOR ANNOUNCES THE PRICING OF €600 MILLION NOTES MATURING IN 2035 Exor N.V. (rated A– with a stable outlook by Standard & Poor’s) announces that it has priced €600 million notes due 5 November 2035 carrying a fixed annual coupon of 3.75%, with an issue price of 99.386%. The purpose of the issue is to raise new funds for Exor’s general corporate purposes, including refinancing of existing debt. The notes will be listed on the Luxembourg Stock Exchange, admitted to trading on the Eu ...

Core Viewpoint - Aya Gold & Silver Inc. is set to release its Boumadine Preliminary Economic Assessment results on November 4, 2025, and will host a live webinar to discuss these results with stakeholders [1]. Company Overview - Aya Gold & Silver Inc. is a rapidly growing silver producer based in Canada, operating in Morocco [3]. - It is the only TSX-listed pure silver mining company, managing the high-grade Zgounder Silver Mine and exploring properties along the Anti-Atlas Fault [3]. Management Focus - The management team is dedicated to maximizing shareholder value by integrating sustainability into its operations, governance, and financial growth strategies [4].

Core Insights - The 2025 Northeast Asia (Shenyang) Conference on Exchange of Professionals aimed to gather global talents to revitalize the region, featuring a record-breaking 84,000 job positions offered by 4,000 employers [2][3] Group 1: Event Overview - The conference took place on October 26, 2025, at the Industrial Museum of China, attracting significant participation with 38,653 attendees on the opening day [3] - A total of 98,000 resumes were received by companies during the event, indicating strong interest from job seekers [3] Group 2: Job Market Insights - The event showcased a total of 84,000 job positions, with 49,000 positions (nearly 60%) in future-oriented industries such as artificial intelligence, advanced materials, new energy, and biomedicine [4] - Popular fields included electrical engineering, mechanical engineering, and embedded software development, reflecting current market trends [4] Group 3: Shenyang's Development Strategy - Shenyang is positioning itself as an international central city in Northeast Asia, focusing on high-quality development and revitalization efforts for Northeast China and Liaoning Province [5] - The city has established five 100-billion-yuan industrial clusters in sectors like automobiles, high-end equipment, and aerospace, supported by 45 universities and 56 major research institutes [3][5] - The "Shenyang Talent Initiative" aims to provide comprehensive support for talent development, enhancing public service resources in education, healthcare, and other sectors [5]

IVECO BUS signs major framework agreements with Île-de-France Mobilités to supply up to 4,000 vehicles Turin, 29th October 2025. IVECO BUS, the urban, intercity and tourist bus brand of Iveco Group N.V. (EXM: IVG), has signed three framework agreements with Île-de-France Mobilités, a leading public transport authority managing one of Europe’s largest and most complex transit networks. IVECO BUS will supply Île-de-France Mobilités with up to 4,000 low- and zero-emission buses and coaches between 2026 and 203 ...

MEDIA RELEASE Paris, 29th October 2025 THE BOARD OF DIRECTORS OF RCI BANQUE S.A. HAS APPROVED THE APPOINTMENT OF PATRICK CLAUDE AS CHAIRMAN OF THE BOARD OF DIRECTORS OF RCI BANQUE S.A. The Board of Directors of RCI Banque S.A., which met on Wednesday 29 October 2025, approved the appointment of Patrick Claude as the new Chairman of the Board of Directors of RCI Banque S.A. Patrick Claude succeeds Gianluca De Ficchy, who is leaving the Group to focus on personal projects. He will work with Martin Tho ...

9-MONTH TURNOVER AS OF SEPTEMBER 30, 2025: +1.4% at €117.4M AT CONSTANT EXCHANGE RATE (*): +1.8%THIRD QUARTER GROWTH: TURNOVER +0.4% at €36.9MAT CONSTANT EXCHANGE RATE (*): +2.2% Blagnac, France, October 29, 2025, after closing of the Stock Market. SOGECLAIR, supplier of innovative solutions with high added value for a safer and less-consuming mobility, announces its turnover over 9 months ending on September 30th, 2025. SOGECLAIR is listed on Euronext Growth Paris. (*) At constant exchange rate: exchange r ...

Core Insights - Tevogen Bio Holdings Inc. emphasizes its biopharma model focused on sustainability and patient affordability, aiming to make precision medicine accessible to all [1] - The company is developing T cell therapies that are off-the-shelf, well-tolerated, and affordable, with a focus on cancers, neurologic diseases, and viral infections, particularly targeting Long COVID [2][2] - Tevogen values its first clinical product, TVGN 489, at $9–$11 billion rNPV, with projected 5-year top-line revenue of approximately $6.5 billion for liver cancer prevention related to chronic Hepatitis B [7] Recent Financial Announcements - Tevogen's financial outlook includes significant revenue projections from its product pipeline, particularly in the context of addressing high-risk chronic Hepatitis B infections [7] Recent Artificial Intelligence Announcements - Tevogen.AI has completed the alpha phase and begun beta build of its proprietary PredicTcell™ model in collaboration with Microsoft and Databricks, which is expected to drastically reduce target analysis time and save billions in drug development costs [7] - The company has received an international patent publication for its AI technology that predicts immunologically active peptides [7] Recent Corporate Announcements - Tevogen has received multiple patents related to Covid-19 and viral infections, enhancing its intellectual property portfolio [5][6] - A dedicated contact channel for Long COVID inquiries has been established, reflecting the global demand for effective solutions [7]

Core Viewpoint - Velcan Holdings reported a significant decrease in net profit for the first half of 2025, primarily due to foreign exchange variations, despite stable turnover and operating costs [2][5]. Financial Performance - Turnover for the first half of 2025 was EUR 1.0 million, showing a 3% increase compared to EUR 1.0 million in the same period of 2024 [2]. - Net result for the first half of 2025 was EUR 0.6 million, a sharp decline of 85% from EUR 4.0 million in the first half of 2024 [2]. - Cash and financial instruments decreased by 3% to EUR 132 million as of June 30, 2025, from EUR 135 million at the end of 2024 [2]. - Consolidated equity remained stable at EUR 135 million [2]. Portfolio and Investment Insights - The portfolio gained EUR 10.8 million excluding forex effects, offset by EUR -8.2 million in currency losses, resulting in a net portfolio gain of EUR 2.6 million compared to EUR 6.1 million in H1 2024 [5]. - As of June 30, 2025, the asset composition included 33% equities, 30% sovereign bonds, 27% cash and equivalents, with the remainder in short positions, BRL/INR instruments, and private equity [5]. - The net cash position was EUR 74.6 million, excluding BRL and INR MM funds [5]. Operational Highlights - Revenue from the Rodeio Bonito hydropower plant in Brazil was EUR 1.0 million, reflecting a 3% year-over-year increase in EUR and a 19% increase in BRL, despite lower production due to drought [5]. - Operating costs remained stable at EUR -2.4 million, with depreciation and provisions at EUR -0.2 million [5]. Shareholder and Market Context - Shareholders' equity amounted to EUR 134.9 million as of June 30, 2025, slightly up from EUR 134.8 million at year-end 2024 [5]. - The company repurchased 32,328 shares for EUR 551,000 under a share buyback program initiated in January 2025 [5]. - The Board clarified that comparisons with other issuers on regulated markets are not relevant due to the distinct regulatory framework of Luxembourg's Euro MTF, where the company's shares are listed [5][11].